Overview of 5-ASA in Therapy of Inflammatory Bowel Disease
There are two forms of 5-aminosalicylic acid (5-ASA) drug delivery. First, a pro-drug form in which 5-ASA, the active principal, is attached to a c.arrier molecule and released in the intestine by bacterial cleavage. An example of this is sulfasalazine, originally developed in the 1940s and found to...
Saved in:
Main Author: | CN Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1994-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1994/756973 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of 5-ASA in IBD Therapy
by: CN Williams
Published: (1994-01-01) -
Therapy of Inflammatory Bowel Disease using New 5-ASA Compounds: An Introduction
by: Ulrich Klotz
Published: (1989-01-01) -
Special Issues in Nutritional Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1993-01-01) -
Trends in Inflammatory Bowel Disease Therapy
by: L Sutherland, et al.
Published: (1990-01-01) -
Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review
by: C.N. Williams
Published: (1987-01-01)